Charles Schwab Investment Management Inc Artivion, Inc. Transaction History
Charles Schwab Investment Management Inc
- $515 Billion
- Q3 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Artivion, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 349,849 shares of AORT stock, worth $9.89 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
349,849
Previous 351,571
0.49%
Holding current value
$9.89 Million
Previous $9.02 Million
3.27%
% of portfolio
0.0%
Previous 0.0%
Shares
29 transactions
Others Institutions Holding AORT
# of Institutions
175Shares Held
36MCall Options Held
33KPut Options Held
900-
Black Rock Inc. New York, NY6.64MShares$188 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.8MShares$79.2 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY2.79MShares$79 Million1.94% of portfolio
-
Macquarie Group LTD Australia, C32.75MShares$77.6 Million0.08% of portfolio
-
Morgan Stanley New York, NY2.45MShares$69.3 Million0.0% of portfolio
About ARTIVION, INC.
- Ticker AORT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 40,316,100
- Market Cap $1.14B
- Description
- Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial...